Reliq Health Technologies Corporate Update

Reliq Health Technologies > Blog Full Left Sidebar > Press Releases > Reliq Health Technologies Corporate Update

VANCOUVER, BC, June 22, 2017 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that further to its news release dated April 21, 2017, the convertible debenture has been converted into Units.

All of the principal amount under the Loans were converted by the Lenders into units (the “Units”) of the Company at a conversion price per Unit of $0.13. Each Unit consists of one (1) common share in the capital of the Company (a “Common Share”) and one-half (1/2) share purchase warrant (a “Warrant”). Each full Warrant entitles the holder to purchase one additional Common Share in the capital of the Company (a “Warrant Share”) at a price of $0.20 per Warrant Share.

Company Overview

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD “Dr. Lisa Crossley”
CEO and Director

For further information contact:

Renmark Financial Communications Inc.

Laura Welsh: lwelsh@renmarkfinancial.com Tel: (416) 644-2020 or (514) 939-3989 www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company”) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.